NCT00653380View on ClinicalTrials.gov

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

October 31, 1999

Study Completion Date

October 31, 1999

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Doxycycline Monohydrate

Capsules, 100 mg, single-dose

DRUG

Monodox

Capsules, 100 mg, single-dose

Trial Locations (1)

G1V 2K8

Anapharm, Inc., Sainte-Foy

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00653380 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions | Biotech Hunter | Biotech Hunter